Discovery of novel indole‐1,2,4‐triazole derivatives as tubulin polymerization inhibitors-Reference-Cited by-同舟云学术

Discovery of novel indole‐1,2,4‐triazole derivatives as tubulin polymerization inhibitors

Published:2021-03-06 Issue:7 Volume:82 Page:1008-1020
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Wu Meng‐Ke¹,Man Ruo‐Jun¹^ORCID,Liao Yan‐Juan¹,Zhu Hai‐Liang²,Zhou Zhu‐Gui³

Affiliation:

1. Guangxi Biological Polysaccharide Separation, Purification and Modification Research Platform Guangxi University for Nationalities Nanning China

2. State Key Laboratory of Pharmaceutical Biotechnology Nanjing University Nanjing China

3. College of Chemistry and Chemical Engineering, Guangxi Key Laboratory of Polysaccharide Materials and Modifications Guangxi University for Nationalities Nanning China

Funder

Natural Science Foundation of Guangxi Province

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21805

Reference40 articles.

1. Microtubule structure and its stabilisation

2. Alkyl-CoA Disulfides as Inhibitors and Mechanistic Probes for FabH Enzymes

3. The Somatic Genomic Landscape of Glioblastoma

4. Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery

5. Microtubule-binding agents: a dynamic field of cancer therapeutics

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel 1,2,4-triazole-maleamic acid derivatives: synthesis and evaluation as anticancer agents with carbonic anhydrase inhibitory activity;Journal of Molecular Structure;2024-10

2. A Review on Indole-triazole Molecular Hybrids as a Leading Edge in Drug Discovery: Current Landscape and Future Perspectives;Current Topics in Medicinal Chemistry;2024-07

3. Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitors;Archiv der Pharmazie;2024-06-21

4. An update on the development on tubulin inhibitors for the treatment of solid tumors;Expert Opinion on Therapeutic Targets;2024-03-03

5. Tubulin polymerization inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024